Skip to main content
Search
Main content
Science
Published

Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes.

Authors

Ross Nortley, Nils Korte, Pablo Izquierdo, Chanawee Hirunpattarasilp, Anusha Mishra, Zane Jaunmuktane, Vasiliki Kyrargyri, Thomas Pfeiffer, Lila Khennouf, Christian Madry, Hui Gong, Angela Richard-Loendt, Wenhui Huang, Takashi Saito, Takaomi C Saido, Sebastian Brandner, Huma Sethi, David Attwell

Abstract

Cerebral blood flow is reduced early in the onset of Alzheimer's disease (AD). Because most of the vascular resistance within the brain is in capillaries, this could reflect dysfunction of contractile pericytes on capillary walls. We used live and rapidly fixed biopsied human tissue to establish disease relevance, and rodent experiments to define mechanism. We found that in humans with cognitive decline, amyloid β (Aβ) constricts brain capillaries at pericyte locations. This was caused by Aβ generating reactive oxygen species, which evoked the release of endothelin-1 (ET) that activated pericyte ETA receptors. Capillary, but not arteriole, constriction also occurred in vivo in a mouse model of AD. Thus, inhibiting the capillary constriction caused by Aβ could potentially reduce energy lack and neurodegeneration in AD.

PMID:31221773 | DOI:10.1126/science.aav9518

UK DRI Authors

Zane Jaunmuktane

Prof Zane Jaunmuktane

Honorary Consultant Neuropathologist, Queen Square Brain Bank, University College London

Prof Zane Jaunmuktane
David Atwell

Prof David Attwell

Centre Director

Investigating how the brain’s energy supply is reduced by a decrease of blood flow in both Alzheimer’s disease and vascular dementia

Prof David Attwell